Restek has expanded its line of Resprep solid phase extraction (SPE) products with the addition of polymeric sorbents, available in both cartridges for high loading capacity and 96-well plates for high throughput and automation. Because Resprep polymeric SPE products feature a silica-free, bonded polymeric material, there are no unwanted secondary silica interactions, even with basic [...]

NEW YORK -- Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and life sciences company focusing on delivering and applying advanced technology capabilities to produce affordable, reliable products and services that enable its customers to meet their clinical needs, today announced it has appointed industry healthcare veteran and leader Rebecca J. Fischer to its Board of Directors. Her appointment [...]

Shimadzu Corporation (Shimadzu) and the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (Providence) in Portland, Oregon, have entered into a joint research agreement to apply mass spectrometry technology to develop tools for personalized cancer immunotherapeutics. Shimadzu and Providence will develop technologies to reliably identify cancer antigens recognized by an individual’s immune [...]

Venlo, The Netherlands – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) today announced that it has concluded the previously announced review of potential strategic alternatives, and has determined the execution of its current stand-alone business plan represents the best opportunity to drive future value creation. The Supervisory Board and Management Board of QIAGEN, in [...]

REDWOOD CITY, Calif.  -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces a license agreement to provide Roche with Codexis’ EvoT4TM DNA ligase high-performance molecular diagnostic enzyme. This enzyme was developed using Codexis’ proprietary CodeEvolver® protein engineering platform and is expected to be incorporated into Roche’s next generation sequencing (NGS) library preparation kits and other [...]

On December 24th, Shimadzu Corporation simultaneously released six new UV-VIS spectrophotometer models under a new UV-i Selection brand. UV-i Selection brand models are equipped standard with LabSolutions UV-Vis analytical data system for UV-VIS spectrophotometers (released April 2018). By including highly user-friendly operability, the ability to automatically analyze multiple samples continuously, and other features for satisfying [...]

SAN DIEGO, California SGI-DNA, Inc., a company dedicated to developing transformative synthetic genomics technologies and revolutionary DBA data storage solutions, today announced the appointment of Brian Donnelly to the newly created position of Chief Commercial Officer.  Mr. Donnelly is a seasoned commercial and operational leader with expertise in developing markets and launching disruptive technologies in [...]

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that the International Trade Commission (ITC) affirmed the Administrative Law Judge’s finding that 10X Genomics infringed three of Bio-Rad’s patents. The Commission also issued a Limited Exclusion Order and Cease and Desist Order against 10X [...]

DUBAI, UAE, December, 2019  – Euformatics, a world-leader in NGS data quality control applications and variant interpretation solutions, has appointed Dubai-headquartered Alliance Global (AGBL) as the exclusive distributor for its bioinformatics software in the Middle East, Asia and Africa. “Euformatics is delighted to be working with Alliance Global as our exclusive distributor in the region to [...]

LAUSANNE, Switzerland –  Nagi Bioscience SA, a Swiss life-science-tech company developing a revolutionary technology for the in vitro testing of drugs and chemicals, announced today the closing of a CHF 1.8 million Seed financing round. Investors in the round include the leading Swiss venture capital platform investiere, Zürcher Kantonalbank, NEST pension fund and private investors from [...]